MCAM and neoplasm: We observed a decrease in mRNA expression of vascular and angiogenic molecules such as mouse Pecam1, Mcam, Pdgf-β receptor, Vegf-a, and the lymphangiogenic growth factors Vegf-c in tumor-bearing mice treated with anti-sMCAM antibody relative to IgG (Figure 7B).